CN105168519A - 具有改善睡眠功能的组合物及其制备方法和应用 - Google Patents
具有改善睡眠功能的组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN105168519A CN105168519A CN201510611451.3A CN201510611451A CN105168519A CN 105168519 A CN105168519 A CN 105168519A CN 201510611451 A CN201510611451 A CN 201510611451A CN 105168519 A CN105168519 A CN 105168519A
- Authority
- CN
- China
- Prior art keywords
- compositions
- component
- medical material
- filter
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 94
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 49
- 241000208340 Araliaceae Species 0.000 claims abstract description 32
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 32
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 32
- 235000008434 ginseng Nutrition 0.000 claims abstract description 32
- 230000000694 effects Effects 0.000 claims abstract description 31
- 210000000582 semen Anatomy 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 64
- 239000012567 medical material Substances 0.000 claims description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- 239000000706 filtrate Substances 0.000 claims description 31
- 239000000284 extract Substances 0.000 claims description 25
- 238000010992 reflux Methods 0.000 claims description 24
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 14
- 238000013461 design Methods 0.000 claims description 12
- 238000004064 recycling Methods 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 239000003826 tablet Substances 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000007902 hard capsule Substances 0.000 claims description 3
- 239000006196 drop Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 36
- 210000002216 heart Anatomy 0.000 abstract description 16
- 210000003734 kidney Anatomy 0.000 abstract description 13
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 210000004072 lung Anatomy 0.000 abstract description 8
- 230000001502 supplementing effect Effects 0.000 abstract description 8
- 210000005036 nerve Anatomy 0.000 abstract description 7
- 210000004185 liver Anatomy 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 239000002671 adjuvant Substances 0.000 abstract description 5
- 239000002994 raw material Substances 0.000 abstract description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 3
- 208000026435 phlegm Diseases 0.000 abstract description 3
- 235000008216 herbs Nutrition 0.000 abstract description 2
- 244000197580 Poria cocos Species 0.000 abstract 2
- 235000008599 Poria cocos Nutrition 0.000 abstract 2
- 230000004438 eyesight Effects 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 23
- 230000000052 comparative effect Effects 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 230000001914 calming effect Effects 0.000 description 13
- 241001465754 Metazoa Species 0.000 description 11
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 11
- 229960002275 pentobarbital sodium Drugs 0.000 description 11
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 9
- 229960003529 diazepam Drugs 0.000 description 9
- 230000002936 tranquilizing effect Effects 0.000 description 9
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 8
- 230000037396 body weight Effects 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 8
- 238000010171 animal model Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 230000004620 sleep latency Effects 0.000 description 4
- -1 C prime Chemical compound 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 229920000881 Modified starch Polymers 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000021438 curry Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000004304 visual acuity Effects 0.000 description 2
- 206010003084 Areflexia Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- JEJFTTRHGBKKEI-OKILXGFUSA-N deoxyschizandrin Chemical compound C1[C@H](C)[C@H](C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-OKILXGFUSA-N 0.000 description 1
- JEJFTTRHGBKKEI-UHFFFAOYSA-N deoxyschizandrin Natural products C1C(C)C(C)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC JEJFTTRHGBKKEI-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000000517 effect on sleep Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000004185 hypothalamic-pituitary-gonadal axis Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000028527 righting reflex Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000004622 sleep time Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510611451.3A CN105168519B (zh) | 2015-09-23 | 2015-09-23 | 具有改善睡眠功能的组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510611451.3A CN105168519B (zh) | 2015-09-23 | 2015-09-23 | 具有改善睡眠功能的组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105168519A true CN105168519A (zh) | 2015-12-23 |
CN105168519B CN105168519B (zh) | 2019-03-19 |
Family
ID=54891274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510611451.3A Active CN105168519B (zh) | 2015-09-23 | 2015-09-23 | 具有改善睡眠功能的组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105168519B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105995425A (zh) * | 2016-05-16 | 2016-10-12 | 广州市好孝心医疗器械有限公司 | 一种药食同源的具有改善睡眠功能的组合物及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101040964A (zh) * | 2007-04-30 | 2007-09-26 | 陈江 | 当归陈皮安眠饮料 |
CN103623218A (zh) * | 2012-08-24 | 2014-03-12 | 上海锦医堂投资管理有限公司 | 一种具有强体、养神功效的中药组合物 |
-
2015
- 2015-09-23 CN CN201510611451.3A patent/CN105168519B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101040964A (zh) * | 2007-04-30 | 2007-09-26 | 陈江 | 当归陈皮安眠饮料 |
CN103623218A (zh) * | 2012-08-24 | 2014-03-12 | 上海锦医堂投资管理有限公司 | 一种具有强体、养神功效的中药组合物 |
Non-Patent Citations (1)
Title |
---|
柴瑞震主编: "《失眠中医食养方》", 30 April 2014 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105995425A (zh) * | 2016-05-16 | 2016-10-12 | 广州市好孝心医疗器械有限公司 | 一种药食同源的具有改善睡眠功能的组合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN105168519B (zh) | 2019-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103789177B (zh) | 一种益气养阴复方太子参保健酒 | |
CN103877263B (zh) | 一种红参、玛咖、绿茶提取物(茶氨酸)等复合中药抗疲劳养生制剂 | |
CN101716240A (zh) | 一种用于改善睡眠、补气生血的制剂 | |
CN106806853A (zh) | 一种缓解体力疲劳和/或提高缺氧耐受力的中药组合物、其制备方法和应用 | |
CN104223297B (zh) | 一种延缓衰老的五味子保健口服液及其制备方法 | |
CN102698077A (zh) | 一种治疗亚健康的中药组合物 | |
CN102008644B (zh) | 一种治疗神经衰弱的药物及其应用 | |
CN105168519A (zh) | 具有改善睡眠功能的组合物及其制备方法和应用 | |
CN102784230B (zh) | 一种治疗营养性贫血的药物组合物制剂 | |
CN115350256A (zh) | 一种治疗失眠的中药组合物及其制备方法 | |
CN104383420A (zh) | 制备治疗失眠多梦药物制剂的方法 | |
CN100360152C (zh) | 一种治疗失眠症的药物组合物及其制备方法 | |
CN104383421A (zh) | 用于失眠多梦的药物制剂 | |
CN104225295A (zh) | 用于改善睡眠的组合物及其制备方法和应用 | |
CN101129633A (zh) | 一种治疗神经衰弱的药物及其制备方法 | |
CN103405574B (zh) | 一种治疗高血压的药物组合物 | |
CN105727089A (zh) | 含艾叶的药物组合物用于制备治疗肠易激综合症药物中的用途 | |
CN101244139B (zh) | 预防或辅助治疗心血管类疾病的中药组合物及其制备方法 | |
CN104435672A (zh) | 一种含有松花粉的提高免疫力的中药组合物 | |
CN103736019B (zh) | 一种治疗失眠多梦的中药制剂 | |
CN104606636B (zh) | 一种治疗抑郁症的中药组合物及其制备方法 | |
CN102727730B (zh) | 治疗男性不育的复方中药制剂及其制备方法 | |
CN103142862B (zh) | 一种可调节免疫功能延缓衰老的口服液及其制备方法 | |
CN102614412A (zh) | 一种解热祛风、镇惊安神的中药组合物 | |
CN103169811A (zh) | 一种改善睡眠的保健药品及制造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
OL01 | Intention to license declared | ||
OL01 | Intention to license declared | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240822 Address after: No.13, 3rd floor, building 1, No.1, Tidu street, Qingyang District, Chengdu, Sichuan 610000 Patentee after: Chengdu yishenrui Technology Co.,Ltd. Country or region after: China Address before: 132013 no.3999 Binjiang East Road, Fengman District, Jilin City, Jilin Province Patentee before: BEIHUA University Country or region before: China |
|
TR01 | Transfer of patent right |
Effective date of registration: 20240828 Address after: 5-548 Huishan Avenue, Huishan District, Wuxi City, Jiangsu Province, 214000 Patentee after: Haofan Xingchen (Wuxi) Biotechnology Co.,Ltd. Country or region after: China Address before: No.13, 3rd floor, building 1, No.1, Tidu street, Qingyang District, Chengdu, Sichuan 610000 Patentee before: Chengdu yishenrui Technology Co.,Ltd. Country or region before: China |